Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma.

PubWeight™: 1.72‹?› | Rank: Top 3%

🔗 View Article (PMC 2718470)

Published in Am J Respir Crit Care Med on May 05, 2005

Authors

Suzy A A Comhair1, Kristin S Ricci, Mercedes Arroliga, Abigail R Lara, Raed A Dweik, Wei Song, Stanley L Hazen, Eugene R Bleecker, William W Busse, Kian Fan Chung, Benjamin Gaston, Annette Hastie, Mark Hew, Nizar Jarjour, Wendy Moore, Stephen Peters, W Gerald Teague, Sally E Wenzel, Serpil C Erzurum

Author Affiliations

1: Department of Pathology, Cleveland Clinic Foundation, OH 44195, USA. comhais@ccf.org

Associated clinical trials:

Adiposity and Airway Inflammation in HIV-Associated Airway Disease (SHOP) | NCT02975258

Articles citing this

Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med (2009) 7.17

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol (2007) 6.33

Oxidative stress and antioxidant defense. World Allergy Organ J (2012) 2.35

Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J Respir Crit Care Med (2011) 1.76

Cigarette smoke-induced mitochondrial fragmentation and dysfunction in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2014) 1.72

Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med (2010) 1.68

Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. J Allergy Clin Immunol (2009) 1.66

Redox control of asthma: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal (2010) 1.43

Alterations of the arginine metabolome in asthma. Am J Respir Crit Care Med (2008) 1.40

Noninvasive markers of airway inflammation in asthma. Clin Transl Sci (2009) 1.15

Glutathione oxidation is associated with airway macrophage functional impairment in children with severe asthma. Pediatr Res (2011) 1.14

Mice deficient in Cu,Zn-superoxide dismutase are resistant to acetaminophen toxicity. Biochem J (2006) 1.02

Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal (2012) 1.01

Transforming growth factor-β and nuclear factor E2–related factor 2 regulate antioxidant responses in airway smooth muscle cells: role in asthma. Am J Respir Crit Care Med (2011) 1.01

Detrimental effects of environmental tobacco smoke in relation to asthma severity. PLoS One (2011) 0.97

Antioxidant components of naturally-occurring oils exhibit marked anti-inflammatory activity in epithelial cells of the human upper respiratory system. Respir Res (2011) 0.96

The protease allergen Pen c 13 induces allergic airway inflammation and changes in epithelial barrier integrity and function in a murine model. J Biol Chem (2011) 0.95

Obesity-asthma association: is it explained by systemic oxidant stress? Chest (2009) 0.94

Relation of oxidant-antioxidant imbalance with disease progression in patients with asthma. Ann Thorac Med (2012) 0.93

Mitochondria in lung diseases. Expert Rev Respir Med (2013) 0.93

Assessment of association of exposure to polycyclic aromatic hydrocarbons with bronchial asthma and oxidative stress in children: A case control study. Indian J Occup Environ Med (2009) 0.90

Exhaled 8-isoprostane in childhood asthma. Respir Res (2005) 0.90

New risk factors for adult-onset incident asthma. A nested case-control study of host antioxidant defense. Am J Respir Crit Care Med (2015) 0.90

The role of oxidative stress in the pathogenesis of asthma. Allergy Asthma Immunol Res (2010) 0.89

Superoxide dismutase 3 controls adaptive immune responses and contributes to the inhibition of ovalbumin-induced allergic airway inflammation in mice. Antioxid Redox Signal (2012) 0.87

Disulfide bond as a switch for copper-zinc superoxide dismutase activity in asthma. Antioxid Redox Signal (2012) 0.86

Oxidative stress in asthma. World Allergy Organ J (2011) 0.85

Genetic ablation of glutaredoxin-1 causes enhanced resolution of airways hyperresponsiveness and mucus metaplasia in mice with allergic airways disease. Am J Physiol Lung Cell Mol Physiol (2012) 0.85

Effect of spirulina intervention on oxidative stress, antioxidant status, and lipid profile in chronic obstructive pulmonary disease patients. Biomed Res Int (2015) 0.84

Hyaluronan and Its Heavy Chain Modification in Asthma Severity and Experimental Asthma Exacerbation. J Biol Chem (2015) 0.84

The Effect of Cigarette Smoke-derived Oxidants on the Inflammatory Response of the Lung. Clin Appl Immunol Rev (2006) 0.83

Antioxidant effect of MnTE-2-PyP on lung in asthma mice model. ScientificWorldJournal (2012) 0.82

Biomarkers in asthma: a real hope to better manage asthma. Clin Chest Med (2012) 0.80

Grape seed proanthocyanidin extract attenuates allergic inflammation in murine models of asthma. J Clin Immunol (2012) 0.79

Severe Asthma in Children: Lessons Learned and Future Directions. J Allergy Clin Immunol Pract (2016) 0.77

Knockout of SOD1 alters murine hepatic glycolysis, gluconeogenesis, and lipogenesis. Free Radic Biol Med (2012) 0.77

Comparison of pre- and post-operative stress levels in patients with allergic rhinitis and non-allergic rhinitis. Eur Arch Otorhinolaryngol (2012) 0.77

The Ethanol Extract of Osmanthus fragrans Flowers Reduces Oxidative Stress and Allergic Airway Inflammation in an Animal Model. Evid Based Complement Alternat Med (2013) 0.76

Coenzyme Q in asthma. Am J Respir Crit Care Med (2015) 0.76

New Insights in Oxidant Biology in Asthma. Ann Am Thorac Soc (2016) 0.76

Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation. Immune Netw (2016) 0.75

Does aspirin-induced oxidative stress cause asthma exacerbation? Arch Med Sci (2015) 0.75

Antioxidant Activity of SOD and Catalase Conjugated with Nanocrystalline Ceria. Bioengineering (Basel) (2017) 0.75

Articles cited by this

Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med (2000) 8.09

Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science (2002) 3.13

The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med (1994) 2.90

Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci U S A (1996) 2.77

Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med (2003) 2.49

A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem (2002) 2.34

NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci U S A (2001) 2.33

Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest (2000) 2.05

Altered lung antioxidant status in patients with mild asthma. Lancet (1999) 2.00

Oxidative and nitrosative events in asthma. Free Radic Biol Med (2003) 1.97

Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med (1999) 1.92

Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol (2002) 1.90

Differential regulation of antioxidant enzymes in response to oxidants. J Biol Chem (1991) 1.73

Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol (2001) 1.69

Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis (1992) 1.57

Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. Am J Pathol (2005) 1.56

Increased oxidative stress and altered levels of antioxidants in asthma. J Allergy Clin Immunol (2003) 1.55

Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem (1999) 1.50

10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem (1994) 1.49

Antioxidant responses to oxidant-mediated lung diseases. Am J Physiol Lung Cell Mol Physiol (2002) 1.45

Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet (2000) 1.43

Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. Am Rev Respir Dis (1993) 1.28

Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite. Arch Biochem Biophys (1999) 1.26

Spectrophotometric assay of superoxide dismutase activity based on the activated autoxidation of a tetracyclic catechol. Anal Biochem (1993) 1.26

Relationship of serum antioxidants to asthma prevalence in youth. Am J Respir Crit Care Med (2003) 1.25

3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo. Biochemistry (1999) 1.24

The relation of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the general population. Am J Respir Crit Care Med (2001) 1.22

Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation. J Biol Chem (1990) 1.21

Extracellular glutathione peroxidase induction in asthmatic lungs: evidence for redox regulation of expression in human airway epithelial cells. FASEB J (2001) 1.19

Quantitative assessment of tyrosine nitration of manganese superoxide dismutase in angiotensin II-infused rat kidney. Am J Physiol Heart Circ Physiol (2003) 1.19

Mitochondrial tyrosine nitration precedes chronic allograft nephropathy. Free Radic Biol Med (2001) 1.19

Enhanced production of oxygen radicals in asthma. J Lab Clin Med (1994) 1.13

Reduced superoxide dismutase in lung cells of patients with asthma. Free Radic Biol Med (1997) 1.13

Inactivation of human Cu,Zn superoxide dismutase by peroxynitrite and formation of histidinyl radical. Free Radic Biol Med (2004) 1.13

Reduced selenium in asthmatic subjects in New Zealand. Thorax (1990) 1.09

Systemic oxidative and antioxidative status in Chinese patients with asthma. J Allergy Clin Immunol (2004) 1.08

Decreased Cu,Zn-SOD activity in asthmatic airway epithelium: correction by inhaled corticosteroid in vivo. Am J Physiol (1997) 1.08

Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids (2000) 1.06

In vivo antioxidant gene expression in human airway epithelium of normal individuals exposed to 100% O2. J Appl Physiol (1985) (1993) 1.04

Inhibition of airway inflammation and hyperreactivity by an antioxidant mimetic. Free Radic Biol Med (2002) 1.04

Increased glutathione and glutathione peroxidase in lungs of individuals with chronic beryllium disease. Am J Respir Crit Care Med (1999) 1.03

Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Respir Dis (1992) 1.03

Increased oxygen species generation in blood monocytes of asthmatic patients. Am Rev Respir Dis (1992) 0.99

Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax (2000) 0.99

Discordant extracellular superoxide dismutase expression and activity in neonatal hyperoxic lung. Am J Respir Crit Care Med (2004) 0.95

Mice that overexpress Cu/Zn superoxide dismutase are resistant to allergen-induced changes in airway control. Am J Physiol Lung Cell Mol Physiol (2000) 0.93

Rat lung Cu,Zn superoxide dismutase. Isolation and sequence of a full-length cDNA and studies of enzyme induction. J Clin Invest (1989) 0.90

Relationship of asthma, atopy, and bronchial responsiveness to serum eosinophil cationic proteins in early childhood. J Allergy Clin Immunol (2004) 0.85

Heparin-, dextran sulfate- and protamine-induced release of extracellular-superoxide dismutase to plasma in pigs. Biochim Biophys Acta (1988) 0.84

Blood antioxidant enzymes as markers of exposure or effect in coal miners. Occup Environ Med (1996) 0.82

Inactivation and oxidative modification of Cu,Zn superoxide dismutase by stimulated neutrophils: the appearance of new catalytically active structures. Biochem Biophys Res Commun (1992) 0.82

Serum eosinophil peroxidase (EPO) levels in asthmatic patients. Allergy (1997) 0.82

Superoxide anion production by monocytes of corticosteroid-treated asthmatic patients. Eur Respir J (1998) 0.81

Airway remodelling takes place in asthma--what are the clinical implications? Clin Exp Allergy (1997) 0.78

Hydrogen peroxide generation in the erythrocytes of newborn infants. Biol Neonate (1970) 0.78

IgE produces monocyte superoxide anion release: correlation with CD23 expression. Comparison of patients with asthma, patients with rhinitis, and normal subjects. J Allergy Clin Immunol (1994) 0.77

Articles by these authors

Cumulative association of five genetic variants with prostate cancer. N Engl J Med (2008) 15.34

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature (2011) 13.53

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med (2013) 9.44

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest (2006) 8.43

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J (2013) 8.39

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med (2004) 8.39

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med (2013) 8.21

Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59

Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med (2009) 7.17

Nurse training in sexual and reproductive health. J Fam Plann Reprod Health Care (2010) 6.34

Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol (2007) 6.33

Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med (2010) 6.19

Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA (2005) 6.14

A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med (2007) 6.02

Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med (2009) 5.90

Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med (2003) 5.89

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet (2012) 5.82

An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med (2011) 5.53

Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet (2011) 5.26

Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet (2003) 5.10

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med (2014) 4.95

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst (2007) 4.85

Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med (2009) 4.83

Respiratory effects of exposure to diesel traffic in persons with asthma. N Engl J Med (2007) 4.58

Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. JAMA (2012) 4.30

Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med (2007) 4.30

Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med (2007) 4.11

Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet (2008) 4.06

Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinoma. J Clin Oncol (2012) 3.98

Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97

Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet (2011) 3.68

Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med (2002) 3.68

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA (2008) 3.64

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest (2004) 3.63

Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA (2012) 3.40

Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol (2011) 3.35

Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol (2007) 3.28

Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA (2007) 3.25

A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J Biol Chem (2002) 3.17

Nitric oxide in health and disease of the respiratory system. Physiol Rev (2004) 3.15

New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14

Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12

A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma. Am J Respir Crit Care Med (2010) 3.11

NHS to receive an extra 40bn pound sterling over next five years. BMJ (2002) 3.10

Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project. PLoS Genet (2011) 3.07

Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks. Arterioscler Thromb Vasc Biol (2013) 3.07

A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab (2006) 3.06

Wanless report outlines "Rolls- Royce" health service for 2022. BMJ (2002) 3.04

Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab (2013) 3.01

Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med (2005) 2.94

Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem (2002) 2.94

Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol (1985) (2007) 2.83

Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet (2009) 2.82

Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med (2004) 2.81

Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol (2004) 2.80

Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation (2004) 2.79

Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD. Thorax (2010) 2.79

TIMI myocardial perfusion frame count: a new method to assess myocardial perfusion and its predictive value for short-term prognosis. Catheter Cardiovasc Interv (2010) 2.78

Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol (2005) 2.77

Seventy-five genetic loci influencing the human red blood cell. Nature (2012) 2.77

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet (2002) 2.76

Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol (2006) 2.67

Causes and circumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med (2013) 2.64

Should we screen for lung cancer in Australia? Med J Aust (2013) 2.62

Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet (2001) 2.61

An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat Med (2012) 2.59